# SPI Pharma, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/spi-pharma-inc/484ad664-00d6-4107-915e-a68a394e0b55

> Inspection records and compliance data for SPI Pharma, Inc. in Grand Haven, Michigan. Access full analysis and detailed observations.

---

## Details

- Name: SPI Pharma, Inc.
- FEI Number: 1833292
- City: Grand Haven
- State: Michigan
- Country Name: United States
- Address Line 1: 1711 Tiles Ct
- Zip Code: 49417
- Business Operations: API MANUFACTURE

## Related Documents

- [FDA Inspection 1291622 - SPI Pharma, Inc. - 2025-09-26](https://www.keypedia.com/records/fda_inspections/spi-pharma-inc/91c91461-cf4e-42b3-b879-de55cc40ce0f) — source: FDA, date: September 26, 2025
- [FDA Inspection 1291622 - SPI Pharma, Inc. - 2025-09-26](https://www.keypedia.com/records/fda_inspections/spi-pharma-inc/eedc8fd1-d70f-4ef3-9b61-24f1f91e81d6) — classification: No Action Indicated (NAI), source: FDA, date: September 26, 2025
- [FDA Inspection 1215641 - SPI Pharma, Inc. - 2023-08-10](https://www.keypedia.com/records/fda_inspections/spi-pharma-inc/56a94f60-3f2a-4e68-87de-3eabcab569bd) — source: FDA, date: August 10, 2023
- [EIR - SPI Pharma, Inc. - 2019-04-29](https://www.keypedia.com/records/eir/spi-pharma-inc/84f8fe72-2ede-4927-a789-aa612d7b4f33) — source: FDA, date: April 29, 2019
- [FDA Inspection 1090151 - SPI Pharma, Inc. - 2019-04-29](https://www.keypedia.com/records/fda_inspections/spi-pharma-inc/25e3df3f-2341-4e01-9ad4-d7554d42a31f) — classification: No Action Indicated (NAI), source: FDA, date: April 29, 2019
- [FDA Inspection 1003696 - SPI Pharma, Inc. - 2017-03-06](https://www.keypedia.com/records/fda_inspections/spi-pharma-inc/5a604014-68e6-4ac9-b44b-2e9b907fd82d) — classification: No Action Indicated (NAI), source: FDA, date: March 6, 2017
- [FDA Inspection 860789 - SPI Pharma, Inc. - 2013-11-19](https://www.keypedia.com/records/fda_inspections/spi-pharma-inc/bbb7ab92-c354-408a-9d9d-c6eef237aea3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 19, 2013
- [FDA Inspection 729481 - SPI Pharma, Inc. - 2011-05-04](https://www.keypedia.com/records/fda_inspections/spi-pharma-inc/0be4a3fc-eac9-48ad-a0ec-6deed51f9f98) — classification: No Action Indicated (NAI), source: FDA, date: May 4, 2011
- [FDA Inspection 662416 - SPI Pharma, Inc. - 2010-05-12](https://www.keypedia.com/records/fda_inspections/spi-pharma-inc/67e19338-d4c6-4076-9160-0d7d2d607a20) — classification: No Action Indicated (NAI), source: FDA, date: May 12, 2010

## Related Companies

- [Ajinomoto Health & Nutrition North America, Inc.](https://www.keypedia.com/companies/ajinomoto-health-nutrition-north-america-inc/4517157b-a19a-436f-a339-7fc5453913c4)
- [Impact Fulfillment Services](https://www.keypedia.com/companies/impact-fulfillment-services/6c3d27f3-2c10-4a93-bdfc-c032bf75b8ee)
- [Suan Farma Inc.](https://www.keypedia.com/companies/suan-farma-inc/98ad3d35-a6bb-4c47-b946-338d246921a8)
- [Magno-Humphries Inc.](https://www.keypedia.com/companies/magno-humphries-inc/1a616827-99d0-40ca-8695-24c1aea546a4)
- [Sample Solutions, LLC](https://www.keypedia.com/companies/sample-solutions-llc/01ff9989-aaee-48c3-b879-657670ab9dc6)
- [AndersonBrecon Inc.](https://www.keypedia.com/companies/andersonbrecon-inc/aefafff0-9d39-4b82-8ebb-44c17e5d0f6d)
- [Reed-Lane, Inc.](https://www.keypedia.com/companies/reed-lane-inc/e035bebf-a204-4064-9cb5-92b6957273e7)
- [Acme United Corporation](https://www.keypedia.com/companies/acme-united-corporation/f719cc33-de99-46c4-b10a-166da1062a14)
- [Sharp Packaging Services, LLC](https://www.keypedia.com/companies/sharp-packaging-services-llc/7b0af746-388f-48e7-8eda-3efbb4ccdab5)
- [Acme United Corporation](https://www.keypedia.com/companies/acme-united-corporation/5f8132f7-2f04-4b45-b932-d2db7b845760)

## Related Officers

- [recipient](https://www.keypedia.com/people/christopher-d-golden/1910fcc3-2b8e-4897-846d-6a1a25e230cb)
- [Supervisory Consumer Safety Officer](https://www.keypedia.com/people/carl-a-huffman/4fa9a65e-2aa5-417c-8369-61edab77c57f)
